UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells

Scientific reports, 2020-02, Vol.10 (1), p.1970, Article 1970

2020

Volltextzugriff (PDF)

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer

Scientific reports, 2021-02, Vol.11 (1), p.2844-2844, Article 2844

2021

Volltextzugriff (PDF)

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Scientific reports, 2019-03, Vol.9 (1), p.4712, Article 4712

2019

Volltextzugriff (PDF)

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

Cancers, 2022-03, Vol.14 (6), p.1588

2022

Volltextzugriff (PDF)

Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer

Scientific reports, 2017-03, Vol.7 (1), p.45060-45060, Article 45060

2017

Volltextzugriff (PDF)

MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer

PloS one, 2019-12, Vol.14 (12), p.e0226356

2019

Volltextzugriff (PDF)

Harnessing Generative Pre-Trained Transformers for Construction Accident Prediction with Saliency Visualization

Applied sciences, 2024-01, Vol.14 (2), p.664

2024

Volltextzugriff (PDF)

New Directions in the Study and Treatment of Metastatic Cancer

Frontiers in oncology, 2018-07, Vol.8, p.258-258

2018

Volltextzugriff (PDF)

Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin

PloS one, 2018-07, Vol.13 (7), p.e0201046-e0201046

2018

Volltextzugriff (PDF)

Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials

Frontiers in oncology, 2022-10, Vol.12, p.959630

2022

Volltextzugriff (PDF)

Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer

Cancer nanotechnology, 2021, Vol.12 (1), p.1-15, Article 16

2021

Volltextzugriff (PDF)

Guidelines for Rational Cancer Therapeutics

Frontiers in oncology, 2017-12, Vol.7, p.310-310

2017

Volltextzugriff (PDF)

Design of nanodrugs for miRNA targeting in tumor cells

Journal of biomedical nanotechnology, 2014-06, Vol.10 (6), p.1114

2014

Volltextzugriff (PDF)

Lanthanide-mediated dephosphorylation used for peptide cleavage during solid phase peptide synthesis

Molecules (Basel, Switzerland), 2013-04, Vol.18 (4), p.3894-3905

2013

Volltextzugriff (PDF)

Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2015-10, Vol.75 (20), p.4407-4415

2015

Volltextzugriff (PDF)

Abstract 1311: PET-MRI microdosing can determine the delivery of the experimental cancer therapeutic, MN-anti-miR10b, to metastatic lesions in a murine model of breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1311-1311

2021

Volltextzugriff (PDF)

A PARACEST MRI Contrast Agent To Detect Enzyme Activity

Journal of the American Chemical Society, 2006-11, Vol.128 (43), p.14032-14033

2006

Volltextzugriff (PDF)

An overview of responsive MRI contrast agents for molecular imaging

Frontiers in bioscience, 2008-01, Vol.13, p.1733

2008

Volltextzugriff (PDF)

Detecting Enzyme Activities with Exogenous MRI Contrast Agents

Chemistry : a European journal, 2014-08, Vol.20 (32), p.9840-9850

2014

Volltextzugriff (PDF)

Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer

International journal of cancer, 2016-08, Vol.139 (3), p.712-718

2016

Volltextzugriff (PDF)

Combination Treatment with Theranostic Nanoparticles for Glioblastoma Sensitization to TMZ

Molecular imaging and biology, 2014-10, Vol.16 (5), p.680-689

2014

Volltextzugriff (PDF)

Abstract 5069: Cancer immunotherapy based on the RNAi-based PD-L1 inhibitor, MN-siPDL1, demonstrates efficacy in preclinical pancreatic adenocarcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5069-5069

2023

Volltextzugriff (PDF)

Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI

Molecular pharmaceutics, 2009-10, Vol.6 (5), p.1409-1416

2009

Volltextzugriff (PDF)

Magnetic resonance imaging of intra‐pancreatic ductal nanoparticle delivery to islet cells

Diabetes/metabolism research and reviews, 2017-07, Vol.33 (5), p.n/a

2017

Volltextzugriff (PDF)

Detection of in vivo enzyme activity with CatalyCEST MRI

Magnetic resonance in medicine, 2014-03, Vol.71 (3), p.1221-1230

2014

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(27)
Humans
(21)
Animals
(17)
Female
(13)
Mice
(13)
Cell Line, Tumor
(12)
Breast Cancer
(9)
Magnetic Resonance Imaging - Methods
(9)
Oncology
(9)
Physical Sciences
(9)
Chemistry
(8)
Metastasis
(8)
Mirna
(8)
Nanoparticles
(8)
Science & Technology - Other Topics
(8)
Biochemistry & Molecular Biology
(7)
Cancer
(7)
Cancer Therapies
(7)
Micrornas - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer

MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer

Harnessing Generative Pre-Trained Transformers for Construction Accident Prediction with Saliency Visualization

New Directions in the Study and Treatment of Metastatic Cancer

Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin

Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials

Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer

Guidelines for Rational Cancer Therapeutics

Design of nanodrugs for miRNA targeting in tumor cells

Lanthanide-mediated dephosphorylation used for peptide cleavage during solid phase peptide synthesis

Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer

Abstract 1311: PET-MRI microdosing can determine the delivery of the experimental cancer therapeutic, MN-anti-miR10b, to metastatic lesions in a murine model of breast cancer

A PARACEST MRI Contrast Agent To Detect Enzyme Activity

An overview of responsive MRI contrast agents for molecular imaging

Detecting Enzyme Activities with Exogenous MRI Contrast Agents

Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer

Combination Treatment with Theranostic Nanoparticles for Glioblastoma Sensitization to TMZ

Abstract 5069: Cancer immunotherapy based on the RNAi-based PD-L1 inhibitor, MN-siPDL1, demonstrates efficacy in preclinical pancreatic adenocarcinoma

Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI

Magnetic resonance imaging of intra‐pancreatic ductal nanoparticle delivery to islet cells

Detection of in vivo enzyme activity with CatalyCEST MRI

Suchergebnisse filtern